Archives

Archive for March, 2011

a deep well…

The National Institutes of Health NOT Friendly to Ghostwriting Project on GovernmentOversight By Paul D. Thacker Mar 01, 2011 Late last year, POGO sent a letter to the National Institutes of Health (NIH) apprising them of four examples of academics who used the ghostwriting firm Scientific Therapeutics Information to publish studies, letters, and a book. […]

contents of an empty mind……

Occasionally, not thinking about things allows some room in the mind to think. I’ve spent weeks reading and rereading these Seroquel Clinical Trials and remained befuddled. The graphs all look almost the same. I even named them after the Companies that make them [Clinical Research Organizations]: The most obvious problem is that the Placebo subjects […]

selling seroquel VIII: CRO-Charts…

I’ve left out a lot – Wayne McFadden’s affair with a Parexel writer, more buried trials [Trial 0031, Trial 0041, etc.], the new XR campaign to stay in the game with depression, and a bunch of email threads showing AstraZeneca‘s  corrupt corporate climate. In one of the comments, PharmaGossip mentions complicity theory: “Complicity works like […]

selling seroquel VII: indication sprawl…

Most of the internal documents from AstraZeneca relate to the first half of the decade when the focus was on the competition among the Atypicals based on efficacy and adverse effects treating Schizophrenia – EPS, TD, weight gain, Diabetes, etc. By mid-decade [CATIE], clinical experience and the longer-term studies had pretty well clarified things for […]